195 related articles for article (PubMed ID: 2925488)
1. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981).
Mooney SC; Hayes AA; MacEwen EG; Matus RE; Geary A; Shurgot BA
J Am Vet Med Assoc; 1989 Mar; 194(5):696-702. PubMed ID: 2925488
[TBL] [Abstract][Full Text] [Related]
2. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
[TBL] [Abstract][Full Text] [Related]
3. Alimentary lymphoma in cats: 28 cases (1988-1993).
Mahony OM; Moore AS; Cotter SM; Engler SJ; Brown D; Penninck DG
J Am Vet Med Assoc; 1995 Dec; 207(12):1593-8. PubMed ID: 7493898
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of lymphoma in 75 cats.
Jeglum KA; Whereat A; Young K
J Am Vet Med Assoc; 1987 Jan; 190(2):174-8. PubMed ID: 3818430
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma in cats treated with a weekly cyclophosphamide-, vincristine-, and prednisone-based protocol: 114 cases (1998-2008).
Waite AH; Jackson K; Gregor TP; Krick EL
J Am Vet Med Assoc; 2013 Apr; 242(8):1104-9. PubMed ID: 23547674
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
Simon D; Eberle N; Laacke-Singer L; Nolte I
J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
MacEwen EG; Hayes AA; Matus RE; Kurzman I
J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats.
Hadden AG; Cotter SM; Rand W; Moore AS; Davis RM; Morrissey P
J Vet Intern Med; 2008; 22(1):153-7. PubMed ID: 18289303
[TBL] [Abstract][Full Text] [Related]
11. Feline mediastinal lymphoma: a retrospective study of signalment, retroviral status, response to chemotherapy and prognostic indicators.
Fabrizio F; Calam AE; Dobson JM; Middleton SA; Murphy S; Taylor SS; Schwartz A; Stell AJ
J Feline Med Surg; 2014 Aug; 16(8):637-44. PubMed ID: 24366846
[TBL] [Abstract][Full Text] [Related]
12. Therapy for Australian cats with lymphosarcoma.
Malik R; Gabor LJ; Foster SF; McCorkell BE; Canfield PJ
Aust Vet J; 2001 Dec; 79(12):808-17. PubMed ID: 11837901
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol.
Teske E; van Straten G; van Noort R; Rutteman GR
J Vet Intern Med; 2002; 16(2):179-86. PubMed ID: 11899035
[TBL] [Abstract][Full Text] [Related]
14. Use of a vascular access system for administration of chemotherapeutic agents to a ferret with lymphoma.
Rassnick KM; Gould WJ; Flanders JA
J Am Vet Med Assoc; 1995 Feb; 206(4):500-4. PubMed ID: 7768701
[TBL] [Abstract][Full Text] [Related]
15. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
16. Principles of treatment for feline lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):98-102. PubMed ID: 12831069
[TBL] [Abstract][Full Text] [Related]
17. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
20. Spinal lymphoma in cats: 21 cases (1976-1989).
Spodnick GJ; Berg J; Moore FM; Cotter SM
J Am Vet Med Assoc; 1992 Feb; 200(3):373-6. PubMed ID: 1548176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
